Journal
CRYSTENGCOMM
Volume 10, Issue 8, Pages 1074-1081Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/b717887e
Keywords
-
Categories
Ask authors/readers for more resources
Five distinct crystal forms of rifaximin (alpha, beta, gamma, delta and epsilon) have been identified and characterised by X- ray powder diffraction, solid state C-13 NMR, and HATR-IR spectroscopy. Changes in the crystal structure may produce differences of two to three orders of magnitude in the rate of intrinsic dissolution, solubility and bioavailability of rifaximin. Alteration of the pharmacokinetic parameters is of particular interest; the C-max values of the crystal forms range from 1.1 to 1085.31 ng ml(-1) and the AUC(0-24) h values range from 10 to 4795 ng h ml(-1). These findings are relevant to the therapeutic use of rifaximin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available